Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

822
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
822
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

148
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
148
Drug Therapy01:28

Drug Therapy

110
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
110
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.2K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.7K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.7K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deprescribing Through the LESS-CHRON Tool: Recruitment Data and Results of Impact on Pharmacological Treatment (LESS-CHRON Validation Project).

Journal of the American Geriatrics Society·2025
Same author

Gender Bias in Clinical Trials of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Systematic Review.

Journal of diabetes research·2025
Same author

ConciliaMed: an interactive mobile and web tool to reconcile chronic medications of patients undergoing elective surgery.

BMJ health & care informatics·2025
Same author

Smartphone Apps for Pulmonary Hypertension: Systematic Search and Content Evaluation.

JMIR mHealth and uHealth·2024
Same author

The Barriers to Deprescription in Older Patients: A Survey of Spanish Clinicians.

Healthcare (Basel, Switzerland)·2023
Same author

Evidence of Immunomodulatory Food-Protein Derived Peptides in Human Nutritional Interventions: Review on the Outcomes and Potential Limitations.

Nutrients·2023

Related Experiment Video

Updated: Oct 2, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization.

Angela María Villalba-Moreno1, Mercedes Galván-Banqueri2, Aitana Rodríguez-Pérez1

  • 1Pharmacy Service, University Hospital Virgen del Rocío, Seville, Spain.

Journal of Medical Systems
|February 28, 2022
PubMed
Summary

CHRONIC-PHARMA is a new web platform that helps manage medications for chronic diseases. It offers tools to reduce anticholinergic burden, deprescribe drugs, and assess adverse drug event risk, improving patient safety.

Keywords:
Anticholinergic burdenChronic patientClinical decision support systemDeprescribingTechnological developmentTrigger tool

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Related Experiment Videos

Last Updated: Oct 2, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Area of Science:

  • Pharmacology
  • Digital Health
  • Geriatrics

Background:

  • Polypharmacy in chronic diseases increases adverse drug events.
  • Optimizing pharmacotherapy is crucial for patient safety and outcomes.
  • Existing tools for medication review are often fragmented.

Purpose of the Study:

  • To introduce CHRONIC-PHARMA, an integrated web platform for pharmacotherapy management in chronic diseases.
  • To provide healthcare professionals with tools for optimizing medication regimens and enhancing patient safety.
  • To facilitate the reduction of anticholinergic burden and deprescribing opportunities.

Main Methods:

  • Development of a web platform integrating three distinct tools: Anticholinergic Burden Calculator (ABC), LESS-CHRON criteria, and TRIGGER-CHRON.
  • The platform focuses on risk estimation, deprescribing identification, and adverse drug event monitoring.
  • Online accessibility via a website and mobile application.

Main Results:

  • CHRONIC-PHARMA integrates multiple pharmacotherapy support functions into a single, accessible platform.
  • The platform aids in estimating and reducing anticholinergic risk.
  • It supports the identification and monitoring of deprescribing opportunities and adverse drug event risks.

Conclusions:

  • CHRONIC-PHARMA offers a valuable, integrated solution for pharmacotherapy optimization in chronically ill patients.
  • The platform enhances medication safety by addressing anticholinergic burden and facilitating deprescribing.
  • Its widespread accessibility promotes improved care for patients with chronic diseases.